Intervenn Biosciences was co-founded by faculty members at Stanford University and University of California, Berkeley.

New and returning investors have chipped into the ETH Zurich plant-based meat spinout’s pre-series B round, five months after it completed a series A.

The MDC spinout raised a series B round which will be used to boost its manufacturing capacity and advance its pipeline of candidates.